AI assistant
SCIDEV LTD — AGM Information 2020
Nov 9, 2020
65761_rns_2020-11-09_d77f7c1a-e24f-429c-86f5-9edfc245b93b.pdf
AGM Information
Open in viewerOpens in your device viewer
SciDev Ltd Annual General Meeting 10th November 2020
Trevor Jones
CHAIRMAN
Making water work harder
SciDev solves operational and environmental issues relating to water across multiple global industrial markets.
Our products and services are backed by expert support from our highly experienced team.


REVENUE A$18m REVENUE GROWTH SciDev's FY20:
+518% YOY
CASH AT BANK (AS AT 30 SEPT 2020)
A$5.6m
SciDev Ltd Annual General Meeting 10th November 2020
Lewis Utting
MANAGING DIRECTOR & CHIEF EXECUTIVE OFFICER
A focused yet rapidly growing company
In the last 12 months, SciDev has generated its growth through targeted business development
The business has scaled accordingly and seamlessly managed significant revenue growth, strong organic growth and customer acquisition.


SciDev Snapshot
| Corporate overview | |
|---|---|
| ASX code | SDV |
| Market cap (at $0.74 per share) | $112m |
| Shares on issue | 152m |
| Cash at bank | $5.6m1 |
| Working capital facility | $8.6m2 |
| Major shareholders3 | % held |
|---|---|
| NuoerGroup | 6% |
| Board and Management | 8% |
| Institutional | 21% |
| Retail | 65% |
Nuoer Group: Leading Chinese chemical company. SciDev has exclusive marketing rights in Oceania and support globally for key target end users and industries
- As at 30 September 2020 2) Drawn $1.1m at 30 September 2020 3) As at 27 July 2020

S C I D E V B O A R D





Jon Gourlay NON-EX ECU TIVE DIRECTOR
Heath Roberts COMPA NY S ECRETA RY
Trevor Jones CH A IRMA N
Lewis Utting CEO & MD
Simone Watt NON-EX ECU TIVE DIRECTOR

E X E C U T I V E M A N A G E M E N T T E A M
John Fehon CFO

Kevin Smith PRESIDENT HFT

Jamiel Muhor BUSINESS DEVEL OPMENT

Jeffrey Zhiang MARKETING & S TRA TEGY DIRECTOR

TECHNICAL DIRECTOR
SCIDEV | INVESTOR PRESENTATION 5
SciDev target four global key verticals

Mining & Mineral Processing
Oil & Gas
Infrastructure & Construction
Water & Wastewater
2020 Revenue
Addressable
Market
SciDev Solutions Mining & Mineral
SciDev is an industry leader in solids-liquid separation in the Mining & Mineral Processing sector.
US$2bn
Global mineral processing chemistry market
A$10m A$2m A$2m A$3m

Engineered performance solutions to recycle, reuse and minimise oilfield water waste.
US$2bn
Specialty & production chemical market in US Oil and Gas industry

Processing Oil & Gas Infrastructure & Construction
Reduce costs and operational downtime in the Construction & infrastructure sectors.
US$1bn
Infrastructure and construction dewatering chemistry market
Water & Wastewater
Leading supplier of treatment and products for the industrial, F&B, and municipal water sectors.
US$6bn
Municipal and industrial water treatment market
SCIDEV | INVESTOR PRESENTATION 6

The market opportunity & competitive landscape
SciDev is focused on fine particle separation chemistry (colloid chemistry), which is a US$11 billion sector within the broader US$100bn global commodity chemistry market.
There is significant opportunity for growth. Our current operational footprint is as follows:




10/11/2020

Outlook
SciDev has a strong growth pipeline and is well positioned to deliver sustainable growth in solid-liquid separation.

10/11/2020

Disclaimer
Important Information
This presentation has been prepared by SciDev Ltd (SciDev) based on information available to it as at the date of this presentation. The information is provided in summary form and does not contain all information necessary to make an investment decision. Hence, no representation is made as to the accuracy, completeness or reliability of the information.
In addition, neither SciDev nor any of its subsidiaries, directors, employees, shareholders nor any other person shall have liability whatsoever to any person for any loss, including without limitation from any fault or negligence arising from this presentation or any information supplied in connection with it. This presentation may contain forward-looking statements and projections. These reflect SciDev's current expectations, based on what it believes to be reasonable assumptions.
SciDev gives no warranty or representation as to its future financial performance or any future matter. Except as required by law or ASX listing rules, SciDev is not obliged to update this presentation after its release, even if matters change materially.
This presentation does not constitute financial advice. Further, this presentation is not and should not be construed as an offer to sell or a solicitation of an offer to buy SciDev securities and may not be relied upon in connection with any purchase of SciDev securities.

Contact
www.scidev.com.au
C E O & M D
Lewis Utting
(+61) 2 9622 5185
I N V E S T O R R E L A T I O N S
Craig Sainsbury
0428 550 499
SciDev 2020 AGM – Proxy Results
| Resolution | Description | For | Against | Discretion | Excluded | Abstain |
|---|---|---|---|---|---|---|
| 1 | Adoption of RemunerationReport | 50,379,832 | 162,255 | 2,490,688 | 854,628 | 25,547 |
| 2 | Re-election of Trevor Jones asDirector | 50,798,338 | 73,824 | 2,489,288 | 0 | 551,500 |
| 3 | Re-election of Simone Watt asDirector | 51,343,853 | 73,309 | 2,494,288 | 0 | 1,500 |
| 4 | Ratify Issue of 192,307 Shares | 50,003,430 | 120,453 | 2,489,288 | 1,268,279 | 31,500 |
| 5 | Ratify Issue of 684,000 Shares | 51,265,854 | 121,308 | 2,494,288 | 0 | 31,500 |
| 6 | Ratify Issue of 11,349,588 Shares | 46,380,486 | 138,453 | 1,201,241 | 6,159,910 | 31,500 |
| 7 | Ratify Issue of 7,692,307 Shares | 27,955,708 | 180,453 | 2,495,143 | 0 | 23,281,646 |
| 8 | Ratify Issue of 436,959 Shares | 51,186,854 | 200,308 | 2,494,288 | 0 | 31,500 |
| 9 | ASX Listing Rule 7.1A PlacementApproval | 51,254,758 | 115,251 | 2,494,318 | 0 | 48,623 |

Financial Overview
| A$000 | FY20 | FY19 | % CHANGE |
|---|---|---|---|
| Revenue | 18,061 | 2,921 | 518% |
| Other Income | 589 | 336 | 75% |
| Raw Materials, Consumables, Change in Inventory | -14,765 | -2,005 | 636% |
| Employee expenses | -2,791 | -1,330 | 110% |
| Engineering Consultant & Professional Fees | -1,242 | -788 | 58% |
| Finance Costs | -35 | -6 | 483% |
| Other Expenses | -2,093 | -1,136 | 84% |
| Loss Before income tax | -2,275 | -2,008 | 13% |
| Income tax benefit/(expense) | 1,400 | -24 | -5933% |
| Loss after Tax | -875 | -2,032 | -57% |
| FX Translation | -36 | ||
| Total Comprehensive Income | -911 | -2,032 | -55% |
SciDev's 1Q FY21 Highlights:
Gross Profit 25%
Versus 17% in FY20
Strong Balance Sheet Working Capital
A$9.4m
AT 30/9/2020
F I N A N C E